EZH2 Contributes To Cisplatin Resistance In Breast Cancer By Epigenetically Suppressing miR-381 Expression

BACKGROUND: Emerging evidence reveals the vital role of enhancer of zeste homolog 2 (EZH2) in cancer chemoresistance. However, its function and molecular mechanisms in breast cancer chemoresistance remain largely unknown. METHODS: Gene expression was evaluated using quantitative real-time PCR (qRT-P...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Onco Targets Ther
Hlavní autoři: Dou, Dongwei, Ge, Xin, Wang, Xinxing, Xu, Xiaodong, Zhang, Zhe, Seng, Jingjing, Cao, Zhang, Gu, Yuanting, Han, Mingli
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2019
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6859472/
https://ncbi.nlm.nih.gov/pubmed/32009798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S214104
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky